Ribbon-cutting today at new bio-tech facility for production of promising new cancer treatment modality

HAYWARD, Calif., May 22, 2019—Mayor Barbara Halliday will join RefleXion Medical President and CEO Todd Powell to celebrate today the opening of Hayward-based RefleXion’s new 50,000 square-foot facility for production of the company’s promising new cancer treatment modality.

The ceremony with local dignitaries, facility tours, a demonstration of RefleXion bio-targeting machine for treatment of early and late stage cancer and award of a company gift to the Cal State East Bay STEM program will start at 1 p.m. and is open to print, broadcast and digital news media.

The new facility contains six state-of-the-art linear accelerator testing vaults for the RefleXion machine, an assembly line to build the machine, and a radiation oncology suite for clinical testing.

• WHERE: 25881 Industrial Blvd., Hayward, Calif., 94545
• WHEN: Today, May 22.  Arrival at 12:30 p.m.  Ceremony begins at 1 p.m.
• WHO:  Todd Powell, president and CEO, RefleXion Medical; Barbara Halliday, Mayor, City of Hayward; Sam Mazin, Ph.D., and Akshay Nanduri, RefleXion Medical’s co-founders; Dr. Erik Helgren, Chair of Cal State East Bay Department of Physics

RefleXion’s biology-guided radiotherapy (BgRT) platform is the first to utilize the cancer itself to guide radiation delivery, even in tumors that are moving.

The patented technology uses positron emission tomography (PET), the gold standard in cancer staging, one day enabling multiple tumors to continuously signal their location during treatment.  PET uses a tracer drug that is accumulated by the tumors and produces emissions illuminating their locations.  The RefleXion machine, which is pending FDA clearance and is not yet commercially available, detects the emissions and immediately sends beamlets of radiation directly to the tumor to destroy it.